Clopidogrel with Aspirin Is the Optimal Antiplatelet Regimen for Intracoronary Stenting Steven R. SteinhublEric J. Topol OriginalPaper Pages: 227 - 231
Aspirin and Ticlopidine After Routine Coronary Stenting: The Gold Standard as of 1999 Peter A. McCulloughKeisha R. Marks OriginalPaper Pages: 233 - 239
Use of Glycoprotein IIb/IIIa Inhibition Plus Fibrinolysis in Acute Myocardial Infarction Michael P. HudsonAdam B. GreenbaumE. Magnus Ohman OriginalPaper Pages: 241 - 245
Emerging Treatment of Acute Coronary Syndromes with Platelet Glycoprotein IIB/IIIA Inhibitors Matthew T. RoeDavid J. Moliterno OriginalPaper Pages: 247 - 257
Heparin Induced Thrombocytopenia: Diagnosis and Contemporary Antithrombin Management James L. Januzzi Jr.Ik-Kyung Jang OriginalPaper Pages: 259 - 264
Efficacy of Abciximab Induced Platelet Blockade Using a Rapid Point of Care Assay Dean J. KereiakesMichele MuellerCharles W. Abbottsmith OriginalPaper Pages: 265 - 276
Plasmin Activation System in Restenosis: Role in Pathogenesis and Clinical Prediction? Gunter ChristKaram KostnerKurt Huber OriginalPaper Pages: 277 - 285
Glycoprotein IIb/IIIa Receptor Inhibition in Interventional Cardiology C. Michael GibsonJohn L. MoynihanSusan J. Marble OriginalPaper Pages: 287 - 302
Antithrombotic Effects of BCH 2763, a New Direct Thrombin Inhibitor, in a Canine Model of Venous Thrombosis Thomas B. McClanahanDiane P. IgnasiakKim P. Gallagher OriginalPaper Pages: 301 - 306
New Thrombolytic Strategy: Bolus Administration of tPA and Urokinase-Fibrinogen Conjugate Alexander V. MaksimenkoElena G. Tischenko OriginalPaper Pages: 307 - 312
Hemostatic Effects of 1 mg Daily Warfarin on Post CABG Patients Jeanine M. WalengaDebra HoppensteadtPost CABG Studies Investigators OriginalPaper Pages: 313 - 318
Low Molecular Weight Heparins in the Cardiac Catheterization Laboratory Gilles MontalescotMarc Cohen OriginalPaper Pages: 319 - 323